# Efficacy and Safety of Ivabradine in Severe Congestive Heart Failure

> **NCT00202579** · PHASE2 · COMPLETED · sponsor: **Institut de Recherches Internationales Servier** · enrollment: 12 (estimated)

## Conditions studied

- Heart Failure, Congestive

## Interventions

- **DRUG:** Ivabradine

## Key facts

- **NCT ID:** NCT00202579
- **Lead sponsor:** Institut de Recherches Internationales Servier
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** —
- **Final completion:** 2006-02
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2024-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00202579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00202579, "Efficacy and Safety of Ivabradine in Severe Congestive Heart Failure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00202579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*